Clinical TrialsNG101 Gene Therapy Reduced Anti-VEGF Injection Frequency by 90% in Mid-Dose... NG101 Gene Therapy Reduced Anti-VEGF Injection Frequency by 90% in Mid-Dose... Read Post »
Clinical TrialsRaniPill RT-114 Shows Strong Bioavailability in Phase 1 Obesity Study RaniPill RT-114 Shows Strong Bioavailability in Phase 1 Obesity Study Read Post »
GenericsNATCO Pharma Secures Tentative US FDA Approval for Generic Olaparib Tablets NATCO Pharma Secures Tentative US FDA Approval for Generic Olaparib Tablets Read Post »
Clinical Trials4D-150 Maintains Vision and Cuts Injection Burden by Up to 87% Over Two Yea... 4D-150 Maintains Vision and Cuts Injection Burden by Up to 87% Over Two Yea... Read Post »
Health TidingsKamuvudine-8 Reduced Geographic Atrophy Progression by 54% in Phase 2 Study Kamuvudine-8 Reduced Geographic Atrophy Progression by 54% in Phase 2 Study Read Post »
Health TidingsInnoCare’s Soficitinib Meets Phase II Endpoint in Vitiligo InnoCare’s Soficitinib Meets Phase II Endpoint in Vitiligo Read Post »
GenericsAmneal Secures FDA Approval for Additional Iohexol Injection Presentations,... Amneal Secures FDA Approval for Additional Iohexol Injection Presentations,... Read Post »
Clinical TrialsInnoCare’s Soficitinib Meets Phase III Endpoint in Atopic Dermatitis InnoCare’s Soficitinib Meets Phase III Endpoint in Atopic Dermatitis Read Post »
Clinical TrialsMMV367 Rapidly Eliminates Blood-Stage Malaria Parasites in Early Study MMV367 Rapidly Eliminates Blood-Stage Malaria Parasites in Early Study Read Post »
Clinical TrialsIBC-Ab002 Shows Early Promise in Phase 1b Alzheimer’s Trial IBC-Ab002 Shows Early Promise in Phase 1b Alzheimer’s Trial Read Post »
Clinical Trials Mergers & AcquisitionsBayer Partners with Henry Ford Health to Expand Clinical Trials Bayer Partners with Henry Ford Health to Expand Clinical Trials Read Post »
New Drug ApprovalSystImmune Wins First Global Approval for Iza-bren, the First EGFR×HER3 Bi... SystImmune Wins First Global Approval for Iza-bren, the First EGFR×HER3 Bi... Read Post »
Health TidingsCamurus CAM2029 NDA Accepted by FDA for Acromegaly Camurus CAM2029 NDA Accepted by FDA for Acromegaly Read Post »
Clinical TrialsTakeda’s Zasocitinib Shows Phase 3 Efficacy in Scalp, Nail, Palmoplantar ... Takeda’s Zasocitinib Shows Phase 3 Efficacy in Scalp, Nail, Palmoplantar ... Read Post »
Clinical TrialsVeradermics Reports Positive Age-Based Phase 2/3 Data for VDPHL01 in Male H... Veradermics Reports Positive Age-Based Phase 2/3 Data for VDPHL01 in Male H... Read Post »
Clinical TrialsEvaxion Reports Three-Year EVX-01 Phase 2 Melanoma Results at ESMO 2026 Evaxion Reports Three-Year EVX-01 Phase 2 Melanoma Results at ESMO 2026 Read Post »
Health TidingsShionogi’s Fetroja sNDA Accepted by FDA for Pediatric Hospital Pneumonia ... Shionogi’s Fetroja sNDA Accepted by FDA for Pediatric Hospital Pneumonia ... Read Post »
Health TidingsFabhalta Secures Full FDA Approval to Slow Kidney Function Decline in IgA N... Fabhalta Secures Full FDA Approval to Slow Kidney Function Decline in IgA N... Read Post »
Clinical TrialsKalaris Reports Positive Phase 1a Results for TH103 in Neovascular AMD Kalaris Reports Positive Phase 1a Results for TH103 in Neovascular AMD Read Post »
Clinical TrialsGSK Ends Camlipixant Development After Mixed CALM Phase III Results GSK Ends Camlipixant Development After Mixed CALM Phase III Results Read Post »
Health TidingsDimerix Acquires Phase 2-Ready DMX-652 for Acute Kidney Injury Dimerix Acquires Phase 2-Ready DMX-652 for Acute Kidney Injury Read Post »
New Drug ApprovalEuropean Commission Approves JASCAYD® (Nerandomilast) for Adults with IPF ... European Commission Approves JASCAYD® (Nerandomilast) for Adults with IPF ... Read Post »
Clinical TrialsFirst KRAS Vaccine Shows Promise for Pancreatic Cancer Prevention First KRAS Vaccine Shows Promise for Pancreatic Cancer Prevention Read Post »
Clinical TrialsModerna Advances mRNA-4200 into Phase 1 Study for Advanced Solid Tumors Moderna Advances mRNA-4200 into Phase 1 Study for Advanced Solid Tumors Read Post »
Health TidingsTrellis Raises $9M to Advance Calpurbatug Phase 2 in Prosthetic Joint Infec... Trellis Raises $9M to Advance Calpurbatug Phase 2 in Prosthetic Joint Infec... Read Post »
Health TidingsMedicus Advances Optimized Phase 2 Teverelix Trial After FDA Feedback Medicus Advances Optimized Phase 2 Teverelix Trial After FDA Feedback Read Post »
Health TidingsKalshi and AppliedXL Launch Prediction Markets for Clinical Trial Outcomes Kalshi and AppliedXL Launch Prediction Markets for Clinical Trial Outcomes Read Post »
Clinical TrialsMeiji Seika Highlights Phase III Nacubactam Trial Results Meiji Seika Highlights Phase III Nacubactam Trial Results Read Post »
ManufacturingGates MRI Taps GSK’s AS01E Adjuvant and Serum Institute of India̵... Gates MRI Taps GSK’s AS01E Adjuvant and Serum Institute of India̵... Read Post »
Clinical TrialsBoehringer Ingelheim Advances First-in-Class Triple Agonist BI 3034701 Into... Boehringer Ingelheim Advances First-in-Class Triple Agonist BI 3034701 Into... Read Post »
New Drug ApprovalNICE Recommends Finerenone for Chronic Heart Failure with Preserved or Mild... NICE Recommends Finerenone for Chronic Heart Failure with Preserved or Mild... Read Post »
Health TidingsCOMP360 Phase 2 Analysis Supports Psilocybin Effects in PTSD COMP360 Phase 2 Analysis Supports Psilocybin Effects in PTSD Read Post »
Clinical TrialsAelis Farma Phase 2b Trial of AEF0217 Clears First IDMC Safety Review in Do... Aelis Farma Phase 2b Trial of AEF0217 Clears First IDMC Safety Review in Do... Read Post »
Health Tidings Mergers & AcquisitionsChai Discovery and argenx Partner to Accelerate AI-Driven De Novo Antibody ... Chai Discovery and argenx Partner to Accelerate AI-Driven De Novo Antibody ... Read Post »
Clinical TrialsKairos Reports Favorable Safety Data for ENV-105 Plus Osimertinib in EGFR-M... Kairos Reports Favorable Safety Data for ENV-105 Plus Osimertinib in EGFR-M... Read Post »
Health Tidings Mergers & AcquisitionsLilly Acquires AtaiBeckley to Advance BPL-003 for Treatment-Resistant Depre... Lilly Acquires AtaiBeckley to Advance BPL-003 for Treatment-Resistant Depre... Read Post »
New Drug ApprovalFDA Approves Merck’s LIPFENDRA as First Oral PCSK9 Inhibitor FDA Approves Merck’s LIPFENDRA as First Oral PCSK9 Inhibitor Read Post »
Clinical TrialsInsmed Report Positive 12-Month Data from the OLE Study of Treprostinil Pal... Insmed Report Positive 12-Month Data from the OLE Study of Treprostinil Pal... Read Post »
Drugs Safety AlertMHRA Warns of Rare Botulism Risk with Botulinum Toxin Products MHRA Warns of Rare Botulism Risk with Botulinum Toxin Products Read Post »
Clinical TrialsChimeric Therapeutics Reports New Tumor Shrinkage Data with CHM CDH17 CAR-T... Chimeric Therapeutics Reports New Tumor Shrinkage Data with CHM CDH17 CAR-T... Read Post »
New Drug ApprovalEuropean Commission Approves Wegovy® Pill as First Oral GLP-1 Therapy for ... European Commission Approves Wegovy® Pill as First Oral GLP-1 Therapy for ... Read Post »
Clinical TrialsORIC Initiates Global Phase 3 Himalayas-1 Trial of Rinzimetostat Plus Darol... ORIC Initiates Global Phase 3 Himalayas-1 Trial of Rinzimetostat Plus Darol... Read Post »
Health TidingsEisai’s Lemborexant Marketing Application Accepted by EMA for Chronic Ins... Eisai’s Lemborexant Marketing Application Accepted by EMA for Chronic Ins... Read Post »
Health TidingsAxsome’s AXS-12 NDA for Narcolepsy Cataplexy Accepted by FDA Axsome’s AXS-12 NDA for Narcolepsy Cataplexy Accepted by FDA Read Post »
Health TidingsVeradermics’ Oral VDPHL01 Shows Strong Hair Growth in Phase 2 Study o... Veradermics’ Oral VDPHL01 Shows Strong Hair Growth in Phase 2 Study o... Read Post »
Health TidingsRAG-17 Reduced SOD1 by 69% in Phase 1 Amyotrophic Lateral Sclerosis Trial RAG-17 Reduced SOD1 by 69% in Phase 1 Amyotrophic Lateral Sclerosis Trial Read Post »
Health TidingsOrelabrutinib Significantly Improves Progression-Free Survival as First-Lin... Orelabrutinib Significantly Improves Progression-Free Survival as First-Lin... Read Post »
Clinical TrialsBPGbio’s BPM31510 Shows Encouraging Survival Signal in Phase 2 Glioblasto... BPGbio’s BPM31510 Shows Encouraging Survival Signal in Phase 2 Glioblasto... Read Post »
Clinical TrialsAllogene’s ALLO-316 Shows 31% Response Rate in CD70-High Advanced Kidney ... Allogene’s ALLO-316 Shows 31% Response Rate in CD70-High Advanced Kidney ... Read Post »
Clinical TrialsBiogen and Eisai Present LEADER Study Results for LEQEMBI at AAIC 2026 Biogen and Eisai Present LEADER Study Results for LEQEMBI at AAIC 2026 Read Post »
